Sen. Bernie Sanders says ‘we will end’ Big Pharma ‘greed,’ pushes bills aimed at slashing drug prices

Image of multicolor pills in blister pack
From Berkeley Lovelace Jr.:
NYSE:PJP January 10, 2019 1:43pm

Will Pharmaceutical ETFs Continue To Rally This Holiday Season? (PJP)

From Zacks: As we head toward the end of 2017, the pharma sector continues to perform well, representing a contrast to 2016 when the sector was under immense pressure due to the drug pricing issue.
NYSE:PJP November 8, 2017 6:11am

It Might Be Time To Buy Pharmaceuticals (PJP)

From Invesco: The pharmaceutical industry has lagged in recent years, due in part to political uncertainty, which has kept a lid on company share prices.
NYSE:PJP July 6, 2017 6:18am

Pharmaceuticals (PJP) Won’t Be The Only Sector Hurt By Legal Pot

marijuana stocks
From Bill Hall: In my most recent Money and Markets articles, I’ve put you on the inside track about a rapidly growing, yet mostly still under-the-radar, industry. One that the world’s super-rich are quietly funding with their own money, in pursuit of potentially eye-popping investment returns.
NYSE:PJP June 19, 2017 6:12am

Time To Buy Pharmaceutical ETFs?

Image of multicolor pills in blister pack
From Zacks: 2016 turned out to be a challenging year for pharma stocks with the sector facing a lot of criticism for rising drug prices. Although the election results provided a breather for the sector on hopes that drug pricing would not be a key focus area under a Donald Trump presidency, the relief rally turned out to be short-lived with the President clarifying his stand on rising drug prices.
NYSE:PJP March 16, 2017 7:32am

Pharma ETFs In Focus As Washington Debates Prescription Drug Pricing

With all of the talk from Capitol Hill in regards to prescription pill prices and proposed healthcare reform, today we hone in on the Pharmaceutical segment within the greater Healthcare industry sector in ETF land.
NYSE:PJP March 2, 2017 12:00pm

Trump’s War On Drug Prices Not The Only Concern For Pharma Companies

Image of multicolor pills in blister pack
From Brad Hoppmann: The news out of Washington keeps flooding out, and specifically news that’s being made straight from the Oval Office.
NYSE:PJP February 1, 2017 7:26am

Are Pharmaceutical Stocks In Trouble?

biotech-medical-pillsFrom Dana Lyons: The post-2009 bull market in drug stocks is currently being threatened, with a key index reaching a critical technical level.
NYSE:PJP September 20, 2016 8:54am

New Global Big Pharma ETN Hits The Market (DRGS, IHE, PJP, XPH, PPH)

Michael Johnston: RBS rolled out its fifth ETN this week, debuting a product that offers exposure to the world’s largest pharmaceutical firms. The new Global Big Pharma ETN (NYSE:DRGS) will seek to replicate
NYSE:DRGS October 25, 2011 11:23pm

Bright Spots In The ETF Landscape: Five Funds Holding Their Value In A Wild 2011 (EWM, DFJ, ENZL, VPU, PJP)

Michael Johnston: So far, this year has been tough for markets around the globe. Since the downgrade of U.S. credit quality in August, equity markets have become plagued with rampant volatility, discouraging capital inflows and prompting many investors to pull out of the markets entirely. Just when the
NYSE:DFJ October 21, 2011 4:47pm

The Pharma Four: Similar ETFs, Different Returns (PPH, XPH, IHE, PJP, XLV)

Jared Cummans: Pharmaceutical companies have long been popular investments as they offer relatively inelastic products as well as strong dividend yields that give both growth and value investors something to buy into. As far as the ETF world is concerned, there are four products that allow investors to gain
NYSE:IHE October 17, 2011 3:35pm

Both Expected Return and Risk Is High For Stocks & ETFs (IYR, SMH, XLU, SPY, XLE, EWM, GLD, EWJ)

Recommended funds. Our main recommendation this week is real estate (NYSE:IYR). Its expected return jumped last week as it gained +4.46% in 5 days on slightly higher volume. However, its risk is high and has increased slightly. Because of the high risk in IYR, some
NASDAQ:IBB July 5, 2011 9:37am

Get Free Updates

Join over 50,000 investors who get the latest news from!

Most Popular

From Our Partners

Explore More from

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again! respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories